Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-18T01:22:24.189Z Has data issue: false hasContentIssue false
  • English
  • Français

Genome-wide screen to identify genetic loci associated with cognitive decline in late-life depression

Published online by Cambridge University Press:  09 July 2020

D. C. Steffens ,
M. E. Garrett ,
K. L. Soldano ,
D. R. McQuoid ,
A. E. Ashley-Koch  and
G. G. Potter
D. C. Steffens*
Affiliation:
Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, USA
M. E. Garrett
Affiliation:
Department of Medicine, Duke University Medicine Center, Durham, NC, USA
K. L. Soldano
Affiliation:
Department of Medicine, Duke University Medicine Center, Durham, NC, USA
D. R. McQuoid
Affiliation:
Department of Psychiatry, Duke University Medicine Center, Durham, NC, USA
A. E. Ashley-Koch
Affiliation:
Department of Medicine, Duke University Medicine Center, Durham, NC, USA
G. G. Potter
Affiliation:
Department of Psychiatry, Duke University Medicine Center, Durham, NC, USA
*
Correspondence should be addressed to: David C. Steffens, MD, MHS, Samuel “Sy” Birnbaum/Ida, Louis and Richard Blum Chair in Psychiatry, Professor and Chair, Department of Psychiatry, University of Connecticut School of Medicine, 263 Farmington Ave, Farmington, CT06030-1410, USA. Phone: +1-860-679-4282; Fax: +1-860-679-1296. Email: steffens@uchc.edu.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

This study sought to conduct a comprehensive search for genetic risk of cognitive decline in the context of geriatric depression.

Design:

A genome-wide association study (GWAS) analysis in the Neurocognitive Outcomes of Depression in the Elderly (NCODE) study.

Setting:

Longitudinal, naturalistic follow-up study.

Participants:

Older depressed adults, both outpatients and inpatients, receiving care at an academic medical center.

Measurements:

The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) neuropsychological battery was administered to the study participants at baseline and a minimum of twice within a subsequent 3-year period in order to measure cognitive decline. A GWAS analysis was conducted to identify genetic variation that is associated with baseline and change in the CERAD Total Score (CERAD-TS) in NCODE.

Results:

The GWAS of baseline CERAD-TS revealed a significant association with an intergenic single-nucleotide polymorphism (SNP) on chromosome 6, rs17662598, that surpassed adjustment for multiple testing (p = 3.7 × 10−7; false discovery rate q = 0.0371). For each additional G allele, average baseline CERAD-TS decreased by 8.656 points. The most significant SNP that lies within a gene was rs11666579 in SLC27A1 (p = 1.1 × 10−5). Each additional copy of the G allele was associated with an average decrease of baseline CERAD-TS of 4.829 points. SLC27A1 is involved with processing docosahexaenoic acid (DHA), an endogenous neuroprotective compound in the brain. Decreased levels of DHA have been associated with the development of Alzheimer’s disease. The most significant SNP associated with CERAD-TS decline over time was rs73240021 in GRXCR1 (p = 1.1 × 10−6), a gene previously linked with deafness. However, none of the associations within genes survived adjustment for multiple testing.

Conclusions:

Our GWAS of cognitive function and decline among individuals with late-life depression (LLD) has identified promising candidate genes that, upon replication in other cohorts of LLD, may be potential biomarkers for cognitive decline and suggests DHA supplementation as a possible therapy of interest.

Keywords

affective disordersdementiagenes
Type
Original Research Article
Information
International Psychogeriatrics , First View , pp. 1 - 9
Copyright
© International Psychogeriatric Association 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexopoulos, G. S., Meyers, B. S., Young, R. C., Mattis, S. and Kakuma, T. (1993). The course of geriatric depression with “reversible dementia”: a controlled study. American Journal of Psychiatry, 150, 1693–1699.Google ScholarPubMed
American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.Google Scholar
Breitner, J. C.et al. (1995). Alzheimer’s disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Archives of Neurology, 52, 763–771.CrossRefGoogle ScholarPubMed
Brzezinska, A., Bourke, J., Rivera-Hernandez, R., Tsolaki, M., Wozniak, J. and Kazmierski, J. (2020). Depression in dementia or dementia in depression? Systematic review of studies and hypotheses. Current Alzheimer Research, 17, 16–28.CrossRefGoogle ScholarPubMed
Butters, M. A.et al. (2004). The nature and determinants of neuropsychological functioning in late-life depression. Archives of General Psychiatry, 61, 587–595.CrossRefGoogle ScholarPubMed
Chandler, M. J.et al. (2005). A total score for the CERAD neuropsychological battery. Neurology, 65, 102–106.CrossRefGoogle ScholarPubMed
Chee, L. Y. and Cumming, A. (2018). Polymorphisms in the Cholinergic Receptors Muscarinic (CHRM2 and CHRM3) genes and Alzheimer’s Disease. Avicenna Journal of Medical Biotechnology, 10, 196–199.Google ScholarPubMed
Davis, L. K.et al. (2011). Copy number variations and primary open-angle glaucoma. Investigative Ophthalmology & Visual Science, 52, 7122–7133.CrossRefGoogle ScholarPubMed
Delaneau, O., Marchini, J. and Zagury, J. F. (2011). A linear complexity phasing method for thousands of genomes. Nature Methods, 9, 179–181.CrossRefGoogle Scholar
Devanand, D. P.et al. (1996). Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Archives of General Psychiatry, 53, 175–182.CrossRefGoogle ScholarPubMed
Diniz, B.S., Butters, M.A., Albert, S.M., Dew, M.A. and Reyholds, C.F.. (2013) Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. British Journal of Psychiatry, 202, 329–335.CrossRefGoogle ScholarPubMed
Fan, Q.et al. (2014). Education influences the association between genetic variants and refractive error: a meta-analysis of five Singapore studies. Human Molecular Genetics, 23, 546–554.CrossRefGoogle ScholarPubMed
Gibson, J.et al. (2017). Assessing the presence of shared genetic architecture between Alzheimer’s disease and major depressive disorder using genome-wide association data. Translational Psychiatry, 7, e1094.CrossRefGoogle ScholarPubMed
Hamilton, G.et al. (2012). Alzheimer’s disease risk factor complement receptor 1 is associated with depression. Neuroscience Letters, 10, 6–9.CrossRefGoogle Scholar
Herbert, J. and Lucassen, P. J. (2016). Depression as a risk factor for Alzheimer’s disease: genes, steroids, cytokines and neurogenesis - what do we need to know? Frontiers in Neuroendocrinology, 41, 153–171.CrossRefGoogle ScholarPubMed
Howie, B. N., Donnelly, P. and Marchini, J. (2009). A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLOS Genetics, 5, e1000529.CrossRefGoogle ScholarPubMed
Jorm, A. F.et al. (1991). Psychiatric history and related exposures as risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studies. International Journal of Epidemiology, 20(suppl 2), S43–S47.CrossRefGoogle ScholarPubMed
Kang, H. J.et al. (2015). Associations of cytokine genes with Alzheimer’s disease and depression in an elderly Korean population. Journal of Neurology, Neurosurgery, and Psychiatry, 86, 1002–1007.CrossRefGoogle Scholar
Kitzlerova, E.et al. (2018). Interactions among polymorphisms of susceptibility loci for Alzheimer’s Disease or depressive disorder. Medical Science Monitor, 24, 2599–2619.CrossRefGoogle ScholarPubMed
Koenig, A. M.et al. (2015). Neuropsychological functioning in the acute and remitted states of late-life depression. Journal of Alzheimer’s Disease, 45, 175–185.CrossRefGoogle ScholarPubMed
Kokmen, E., Beard, C. M., Chandra, V., Offord, K. P., Schoenberg, B. S. and Ballard, D. J. (1991). Clinical risk factors for Alzheimer’s disease: a population-based case-control study. Neurology, 41, 1393–1397.CrossRefGoogle ScholarPubMed
Lee, J. S., Potter, G. G., Wagner, H. R., Welsh-Bohmer, K. A. and Steffens, D. C. (2007). Persistent mild cognitive impairment in geriatric depression. International Psychogeriatrics, 19, 125–135.CrossRefGoogle ScholarPubMed
Lehrer, S. (2018). Glioma and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 2, 213–218.Google ScholarPubMed
Lutz, M.W., Sprague, D., Barrera, J. and Chiba-Falek, O. (2020). Shared genetic etiology underlying Alzheimer’s Disease and major depressive disorder. Translational Psychiatry, 10, 88.CrossRefGoogle ScholarPubMed
Mackin, R. S.et al. (2014). Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunction. American Journal of Geriatric Psychiatry , 22, 1496–1503.CrossRefGoogle ScholarPubMed
McKeith, I. G.et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 1113–1124.CrossRefGoogle Scholar
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939–944.CrossRefGoogle ScholarPubMed
Morris, J. C.et al. (1989). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology, 39, 1159–1165.Google Scholar
Ochiai, Y., Uchida, Y., Tachikawa, M., Couraud, P. O. and Terasaki, T. (2019). Amyloid beta25-35 impairs docosahexaenoic acid efflux by down-regulating fatty acid transport protein 1 (FATP1/SLC27A1) protein expression in human brain capillary endothelial cells. Journal of Neurochemistry, 150, 385–401.CrossRefGoogle ScholarPubMed
Ong, S. Y.et al. (2013). Myopia and cognitive dysfunction: the Singapore Malay Eye Study. Investigative Ophthalmology & Visual Science, 54, 799–803.CrossRefGoogle ScholarPubMed
Patterson, N., Price, A. L. and Reich, D. (2006). Population structure and eigenanalysis. PLoS Genetics, 2, e190.CrossRefGoogle ScholarPubMed
Plassman, B. L.et al. (2000). Documented head injury in early adulthood increases risk of Alzheimer’s disease and other dementias 50 years later. Neurology, 55, 1158–1166.CrossRefGoogle Scholar
Plassman, B. L.et al. (2006). Duke twins study of memory in aging in the NAS-NRC Twin Registry. Twin Research and Human Genetics, 9, 950–957.CrossRefGoogle ScholarPubMed
Plassman, B. L.et al. (2007). Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology, 29, 125–132.CrossRefGoogle ScholarPubMed
Purcell, S.et al. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics, 81, 559–575.CrossRefGoogle ScholarPubMed
Ripke, S., Neale, B. M., Corvin, A., Walters, J. T. R., Farh, K. H. and Holmans, P. A. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511, 421–427.Google Scholar
Roman, G. C.et al. (1993). Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250–260.CrossRefGoogle Scholar
Rossetti, H. C., Munro Cullum, C., Hynan, L. S. and Lacritz, L. H. (2010). The CERAD neuropsychologic battery total score and the progression of Alzheimer disease. Alzheimer Disease and Associated Disorders, 24, 138–142.CrossRefGoogle ScholarPubMed
Rutherford, B. R., Brewster, K., Golub, J. S., Kim, A. H. and Roose, S. P. (2018). Sensation and psychiatry: linking age-related hearing loss to late-life depression and cognitive decline. American Journal of Psychiatry, 175, 215–224.CrossRefGoogle ScholarPubMed
Rutten-Jacobs, L. C. A.et al. (2018). Genetic study of white matter integrity in UK Biobank (N=8448) and the overlap with stroke, depression, and dementia. Stroke, 49, 1340–1347.CrossRefGoogle ScholarPubMed
Saczynski, J. S., Beiser, A., Seshadri, S., Auerbach, S., Wolf, P. A. and Au, R. (2010). Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology, 75, 35–41.CrossRefGoogle ScholarPubMed
Saunders, A. M.et al. (1993). Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer’s disease. Neurology, 43, 1467–1472.CrossRefGoogle Scholar
Schraders, M.et al. (2010). Homozygosity mapping reveals mutations of GRXCR1 as a cause of autosomal-recessive nonsyndromic hearing impairment. American Journal of Human Genetics, 86, 138–147.CrossRefGoogle ScholarPubMed
Speck, C. E.et al. (1995). History of depression as a risk factor for Alzheimer’s disease. Epidemiology, 6, 366–369.CrossRefGoogle ScholarPubMed
Srour, M.et al. (2017). Dysfunction of the cerebral glucose transporter SLC45A1 in individuals with intellectual disability and epilepsy. American Journal of Human Genetics, 100, 824–830.CrossRefGoogle ScholarPubMed
Steffens, D. C., McQuoid, D. R. and Krishnan, K. R. (2002a). The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) approach. Psychopharmacology Bulletin, 36, 58–68.Google ScholarPubMed
Steffens, D. C., McQuoid, D. R. and Potter, G. G. (2009). Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study. Journal of Geriatric Psychiatry and Neurology, 22, 52–61.CrossRefGoogle ScholarPubMed
Steffens, D. C., Plassman, B. L., Helms, M. J., Welsh-Bohmer, K. A., Saunders, A. M. and Breitner, J. C. (1997). A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer’s disease. Biological Psychiatry, 41, 851–856.CrossRefGoogle ScholarPubMed
Steffens, D. C.et al. (2007). Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the Neurocognitive Outcomes of Depression in the Elderly study. American Journal of Geriatric Psychiatry, 15, 839–849.CrossRefGoogle ScholarPubMed
Steffens, D. C.et al. (2004). Methodology and preliminary results from the Neurocognitive Outcomes of Depression in the Elderly study. Journal of Geriatric Psychiatry and Neurology, 17, 202–211.CrossRefGoogle ScholarPubMed
The Lund and Manchester Groups (1994). Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 57, 416–418.CrossRefGoogle Scholar
van den Boom, J., Wolter, M., Blaschke, B., Knobbe, C. B. and Reifenberger, G. (2006). Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction. International Journal of Cancer, 119, 2330–2338.CrossRefGoogle ScholarPubMed
White, C. C.et al. (2017). Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLOS Medicine, 14, e1002287.CrossRefGoogle ScholarPubMed
Ye, Q., Bai, F. and Zhang, Z. (2016). Shared genetic risk factors for late-life depression and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 52, 1–15.CrossRefGoogle ScholarPubMed
Zettergren, A.et al. (2017). The ACE gene is Aasociated with late-life major depression and age at dementia onset in a population-based cohort. American Journal of Geriatric Psychiatry, 25, 170–177.CrossRefGoogle Scholar
Zihl, J., Reppermund, S., Thum, S. and Unger, K. (2010). Neuropsychological profiles in MCI and in depression: differential cognitive dysfunction patterns or similar final common pathway disorder? Journal of Psychiatric Research, 44, 647–654.CrossRefGoogle ScholarPubMed